Below are the financial statements of Insmed, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of USD | 2024 | 2023 | 2022 |
|---|---|---|---|
| Product revenues, net | 363.71a | 305.21a | 245.36a |
| Operating expenses | — | — | — |
| Cost of product revenues (excluding amortization of intangible assets) | -85.74a | -65.57a | -55.13a |
| Research and development | -598.37a | -571.01a | -397.52a |
| Selling, general and administrative | -461.12a | -344.5a | -265.78a |
| Amortization of intangible assets | -5.05a | -5.05a | -5.05a |
| Change in fair value of deferred and contingent consideration liabilities | -91.68a | -28.7a | -20.8a |
| Total operating expenses | -1,241.96a | -1,014.83a | -702.68a |
| Operating loss | -878.25a | -709.63a | -457.32a |
| Investment income | 53.31a | 42.13a | 11.08a |
| Interest expense | -84.91a | -81.69a | -26.45a |
| Change in fair value of interest rate swap | -0.24a | 0.32a | -1.53a |
| Other income (expense), net | 0.03a | 1.86a | -5.94a |
| Loss before income taxes | -910.07a | -747.01a | -480.15a |
| Provision for income taxes | -3.71a | -2.56a | -1.38a |
| Net loss | -913.77a | -749.57a | -481.53a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Insmed’s data sources below and access millions more through our Disclosure Search.
Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.